BAJAJHCARE331.50

Bajaj Healthcare Limited

· Pharma & Health
₹ CrorePeersTHEMISMEDLINCOLNWANBURYSIGACHIAHCLANUHPHRAMRUTANJANMcap ₹1,116 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Returns
Return on Common Equity-30.108.472.962.96
Return on Assets-10.954.741.711.71
Return on Capital Employed12.499.7212.8012.80
Return on Invested Capital6.877.417.818.20
Margins
EBITDA Margin16.1115.1917.1517.37
Operating Margin10.2810.0512.6512.65
Incremental Operating Margin8.4733.26
Pretax Margin-3.528.484.734.91
Net Income Margin-17.707.282.582.81
FCF Margin13.101.862.412.41
Additional
Effective Tax Rate14.096.6926.3225.37
Dvd Payout Ratio-3.296.9920.03
Sustainable Growth Rate-31.097.882.372.96
Incremental Operating Margin %8.4733.2617.06
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.